P
ELAN icon

&Partners’s Elanco Animal Health ELAN Stock Holding History

&Partners’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$763K Buy
31,877
+7,370
+30% +$180K ﹤0.01% 1455
2025
Q4 		$555K Sell
24,507
-4,005
-14% -$87.2K ﹤0.01% 1550
2025
Q3 		$573K Buy
28,512
+399
+1% +$6.68K ﹤0.01% 1375
2025
Q2 		$400K Buy
28,113
+3,468
+14% +$40.5K ﹤0.01% 1459
2025
Q1 		$260K Buy
24,645
+14,147
+135% +$160K ﹤0.01% 1484
2024
Q4 		$126K Buy
+10,498
New +$137K ﹤0.01% 1589

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

&Partners's ELAN Position: Q1 2026 in Review

&Partners increased its Elanco Animal Health (ELAN) stake by 30% in Q1 2026, buying an estimated $180K and bringing the position to 31,877 shares worth $763K. The position accounts for ﹤0.01% of the portfolio, ranked #1455.

&Partners first reported a position in ELAN in Q4 2024 and has held it in 6 quarters since. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • &Partners held 31,877 shares of Elanco Animal Health worth $763K as of Q1 2026.
  • &Partners bought 7,370 Elanco Animal Health shares in Q1 2026, an estimated $180K.
  • Elanco Animal Health made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1455 holding.
  • &Partners first reported a position in Elanco Animal Health in Q4 2024 and has held it in 6 quarters since.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.